AimPlex Biosciences

AimPlex Biosciences is a private, commercial-stage company providing multiplex immunoassay services and products for the research diagnostics market. Founded in 2011 (re-established in 2017), the company's core offering is a customizable menu of approximately 500 bead-based assays that enable simultaneous measurement of multiple analytes using standard flow cytometry equipment. With a management team boasting over 55 years of combined experience from major biomedical firms, AimPlex focuses on delivering high-sensitivity detection reagents to improve assay performance and efficiency for its clients. The company operates on a diagnostics and services business model, generating revenue through the sale of its premixed panels and custom assay development services.

Bead-based multiplexed immunoassay panels optimized for use on standard flow cytometers. Enables high-sensitivity, simultaneous detection of multiple analytes (cytokines, chemokines, growth factors, etc.) from a single small sample volume.

AimPlex competes in the multiplex immunoassay space against major players like Luminex (DiaSorin), Bio-Rad, and Bio-Techne (R&D Systems), which offer broader product portfolios and integrated systems. Its differentiation lies in a focus on customization, open-platform compatibility with standard flow cytometers, and potentially lower cost. Niche players and other custom service providers also represent competition.